Unusual behavioral profile of alprazolam in squirrel monkeys. 1990

J G Wettstein
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.

Alprazolam was studied for its effects on schedule-controlled behavior of squirrel monkeys. Monkeys responded by pressing a lever under fixed-ratio or two separate fixed-interval (FI) schedules. Responding was maintained by the presentation of food under all three schedules and was suppressed under one of the FI schedules by electric shock. Unlike lorazepam, alprazolam did not increase rates of either suppressed or nonsuppressed responding under the two FI schedules after acute administration. When given for 3 (at 0.03 mg/kg) or 11 (at 0.1 mg/kg) consecutive days immediately before test sessions, alprazolam also did not increase suppressed responding. Under all three schedules, alprazolam (0.03-3.0 mg/kg) produced dose-dependent decreases in response rate. The rate-decreasing effects of alprazolam were attenuated by drugs known to have benzodiazepine (BZ) antagonist action: Ro 15-1788 (0.01 and 0.3 mg/kg), Ro 15-4513 (0.01 and 0.1 mg/kg) and 3-(methoxycarbonyl)amino-beta-carboline (10.0 and 30.0 mg/kg). These latter drugs alone either had no effect on or decreased fixed-ratio responding. Alprazolam also was tested in combination with lorazepam under the two FI schedules. In general, low doses of lorazepam, equal to or less than those having little effect on response rate when given alone, increased suppressed and nonsuppressed responding when combined with low to moderate doses of alprazolam. The results show that although the rate-decreasing effects of alprazolam probably are due to actions at BZ recognition sites, alprazolam alone does not have typical BZ-like agonist effects on FI responding; it did, however, potentiate the behavioral effects of lorazepam.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008140 Lorazepam A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent. Apo-Lorazepam,Ativan,Donix,Duralozam,Durazolam,Idalprem,Laubeel,Lorazep Von Ct,Lorazepam Medical,Lorazepam-Neuraxpharm,Lorazepam-Ratiopharm,Novo-Lorazem,Nu-Loraz,Orfidal Wyeth,Sedicepan,Sinestron,Somagerol,Temesta,Tolid,Témesta,WY-4036,Apo Lorazepam,Lorazepam Neuraxpharm,Lorazepam Ratiopharm,Medical, Lorazepam,Novo Lorazem,Nu Loraz,Von Ct, Lorazep,WY 4036,WY4036,Wyeth, Orfidal
D008297 Male Males
D011597 Psychomotor Performance The coordination of a sensory or ideational (cognitive) process and a motor activity. Perceptual Motor Performance,Sensory Motor Performance,Visual Motor Coordination,Coordination, Visual Motor,Coordinations, Visual Motor,Motor Coordination, Visual,Motor Coordinations, Visual,Motor Performance, Perceptual,Motor Performance, Sensory,Motor Performances, Perceptual,Motor Performances, Sensory,Perceptual Motor Performances,Performance, Perceptual Motor,Performance, Psychomotor,Performance, Sensory Motor,Performances, Perceptual Motor,Performances, Psychomotor,Performances, Sensory Motor,Psychomotor Performances,Sensory Motor Performances,Visual Motor Coordinations
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004597 Electroshock Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. Electroconvulsive Shock,Electroconvulsive Shocks,Electroshocks,Shock, Electroconvulsive,Shocks, Electroconvulsive
D005442 Flumazenil A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses. Flumazepil,Anexate,Lanexat,Ro 15-1788,Romazicon,Ro 15 1788,Ro 151788
D000525 Alprazolam A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238) Alprazolan,Alprox,Apo-Alpraz,Cassadan,D-65MT,Esparon,Kalma,Novo-Alprazol,Nu-Alpraz,Ralozam,Tafil,Trankimazin,U-31,889,Xanax,Apo Alpraz,D65MT,Novo Alprazol,Nu Alpraz,U31,889
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001386 Azides Organic or inorganic compounds that contain the -N3 group. Azide

Related Publications

J G Wettstein
January 1989, Pharmacology, biochemistry, and behavior,
J G Wettstein
October 1986, The Journal of pharmacology and experimental therapeutics,
J G Wettstein
November 1978, Pharmacology, biochemistry, and behavior,
J G Wettstein
February 1985, The Journal of pharmacology and experimental therapeutics,
J G Wettstein
March 1981, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!